Related Experiment Video
Updated: Aug 8, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Cryptosporidiosis in HIV-seropositive patients
C Blanshard1, A M Jackson, D C Shanson
1HIV/GUM Unit, Westminster Hospital, London.
Abstract:
The incidence of cryptosporidiosis in our unit has increased over the last 6 years, being diagnosed in approximately 5 per cent of all patients with HIV infection and in 21 per cent of those with AIDS, but a marked seasonal variation occurs. We have studied the course of the infection in 128 patients and identified four clinical patterns of disease: transient (28.7 per cent), chronic (59.7 per cent), fulminant (7.8 per cent) and asymptomatic (3.9 per cent). Transient disease occurred in patients with a wide range of CD4 lymphocyte counts, but was more common in less immunosuppressed patients. Fulminant disease, defined by the passage of more than 2 l of stool/day from the time of presentation, only occurred in patients with a CD4 count less than 50/mm3. This group had lost more than 7 kg in weight at presentation and more commonly had other intercurrent gastrointestinal infections. They survived for a median of only 5 weeks, compared with 20 weeks for those with chronic diarrhoea and 36 weeks for those with transient infection. The survival was unaffected by any treatment other than zidovudine. Cryptosporidiosis in HIV-infected individuals is a heterogeneous disease.
Insights
Cryptosporidiosis in HIV patients presents with varied clinical patterns, including transient, chronic, and fulminant disease. Survival is significantly impacted by disease severity and CD4 counts, with zidovudine being the only effective treatment.
Area of Science:
- Infectious Diseases
- Immunology
- Gastroenterology
Background:
- Cryptosporidiosis incidence is rising in HIV-infected individuals, particularly those with AIDS.
- A significant seasonal variation in cryptosporidiosis cases has been observed.
- The disease course in Human Immunodeficiency Virus (HIV) patients is not fully understood.
Purpose of the Study:
- To investigate the clinical patterns and outcomes of cryptosporidiosis in HIV-infected patients.
- To identify factors influencing disease severity and patient survival.
- To understand the heterogeneity of cryptosporidiosis in this population.
Main Methods:
- Retrospective study of 128 HIV-infected patients diagnosed with cryptosporidiosis.
- Classification of disease into four clinical patterns: transient, chronic, fulminant, and asymptomatic.
- Analysis of CD4 lymphocyte counts, weight loss, and co-infections.
Main Results:
- Four clinical patterns identified: transient (28.7%), chronic (59.7%), fulminant (7.8%), and asymptomatic (3.9%).
- Fulminant disease (stool >2L/day) occurred in patients with CD4 <50/mm3, significant weight loss, and other infections, with a median survival of 5 weeks.
- Survival varied by pattern: transient (36 weeks), chronic (20 weeks), and fulminant (5 weeks). Zidovudine was the only treatment impacting survival.
Conclusions:
- Cryptosporidiosis in HIV-infected individuals is a heterogeneous disease with distinct clinical presentations.
- CD4 count is a critical determinant of disease severity and prognosis.
- Fulminant cryptosporidiosis carries a poor prognosis, highlighting the need for effective management strategies.
Related Concept Videos
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Toxoplasmosis
Amebiasis

